Cargando…
Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198395/ https://www.ncbi.nlm.nih.gov/pubmed/32403033 http://dx.doi.org/10.1016/j.thromres.2020.05.001 |
| _version_ | 1783528974438105088 |
|---|---|
| author | Zachariah, U. Nair, S.C. Goel, A. Balasubramanian, K.A. Mackie, I. Elias, E. Eapen, C.E. |
| author_facet | Zachariah, U. Nair, S.C. Goel, A. Balasubramanian, K.A. Mackie, I. Elias, E. Eapen, C.E. |
| author_sort | Zachariah, U. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7198395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71983952020-05-05 Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid Zachariah, U. Nair, S.C. Goel, A. Balasubramanian, K.A. Mackie, I. Elias, E. Eapen, C.E. Thromb Res Article Elsevier Ltd. 2020-08 2020-05-05 /pmc/articles/PMC7198395/ /pubmed/32403033 http://dx.doi.org/10.1016/j.thromres.2020.05.001 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Zachariah, U. Nair, S.C. Goel, A. Balasubramanian, K.A. Mackie, I. Elias, E. Eapen, C.E. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title | Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title_full | Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title_fullStr | Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title_full_unstemmed | Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title_short | Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
| title_sort | targeting raised von willebrand factor levels and macrophage activation in severe covid-19: consider low volume plasma exchange and low dose steroid |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198395/ https://www.ncbi.nlm.nih.gov/pubmed/32403033 http://dx.doi.org/10.1016/j.thromres.2020.05.001 |
| work_keys_str_mv | AT zachariahu targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT nairsc targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT goela targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT balasubramanianka targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT mackiei targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT eliase targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid AT eapence targetingraisedvonwillebrandfactorlevelsandmacrophageactivationinseverecovid19considerlowvolumeplasmaexchangeandlowdosesteroid |